Wiskott-Aldrich 综合征

O'Sullivan E, Kinnon C, Brickell P. Wiskott-Aldrich syndrome protein, WASP. Int J Biochem Cell Biol. 1999;31:383-387.

• 摘要

Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.

• 全文
• 摘要

Burns S, Cory GO, Vainchenker W, et al. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454-3462.

• 全文
• 摘要

Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.

• 全文
• 摘要

1.  O'Sullivan E, Kinnon C, Brickell P. Wiskott-Aldrich syndrome protein, WASP. Int J Biochem Cell Biol. 1999;31:383-387.

• 摘要

2.  Parolini O, Ressmann G, Haas OA, et al. X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med. 1998;338:291-295.

• 全文
• 摘要

3.  Andreu N, Pujol-Moix N, Martinez-Lostao L, et al. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells Mol Dis. 2003;31:332-337.

• 摘要

4.  Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.

• 全文
• 摘要

5.  Lum LG, Tubergen DG, Corash L, et al. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med. 1980;302:892-896.

• 摘要

6.  Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985;65:1439-1443.

• 全文
• 摘要

7.  Litzman J, Jones A, Hann I, et al. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75:436-439.

• 全文
• 摘要

8.  Watanabe N, Yoshimi A, Kamachi Y, et al. Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features. J Pediatr Hematol Oncol. 2007;29:836-838.

• 摘要

9.  Perry GS 3rd, Spector BD, Schuman LM, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr. 1980;97:72-78.

• 摘要

10.  Thrasher AJ, Kinnon C. The Wiskott-Aldrich syndrome. Clin Exp Immunol. 2000;120:2-9.

• 全文
• 摘要

11.  Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644. [Erratum in: Cell. 1994;79:following 922.]

• 摘要

12.  Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;79:following 922. [Erratum for Cell. 1994;78:635-644.]

• 摘要

13.  Online Mendelian Inheritance in Man (OMIM). #301000 Wiskott-Aldrich Syndrome. January 2014. http://omim.org/ (last accessed 16 November 2016).

• 全文

14.  Burns S, Cory GO, Vainchenker W, et al. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454-3462.

• 全文
• 摘要

15.  Maillard MH, Cotta-De-Almeida V, Takeshima F, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4 (+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med. 2007;204:381-391.

• 全文
• 摘要

16.  Marangoni F, Trifari S, Scaramuzza S, et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med. 2007;204:369-380.

• 全文
• 摘要

17.  Rivers E, Worth A, Thrasher AJ, et al. Bleeding and splenectomy in Wiskott-Aldrich syndrome: A single-centre experience. J Allergy Clin Immunol Pract. 2018 Jul 23. pii: S2213-2198(18)30440-9.

• 摘要

18.  Worth AJ, Thrasher AJ. Current and emerging treatment options for Wiskott-Aldrich syndrome. Expert Rev Clin Immunol. 2015;11:1015-1032.

• 摘要

19.  Hacein-Bey Abina S, Gaspar HB, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015;313:1550-1563.

• 摘要

20.  Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013;341:1233151.

• 全文
• 摘要

21.  Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622-e627.

• 全文
• 摘要

22.  Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.

• 全文
• 摘要

23.  Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008;111:439-445.

• 全文
• 摘要

24.  Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 Wiskott-Aldrich syndrome patients treated by hematopoietic cell transplantation between 1980-2009: an international collaborative study. Blood. 2011;118:1675-1684.

• 全文
• 摘要

25.  Elfeky RA, Furtado-Silva JM, Chiesa R, et al. One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years. J Allergy Clin Immunol. 2018 Jul 25. pii: S0091-6749(18)31059-5.

• 摘要